Category: News

Oraya presents data from INTREPID study of stereotactic radiotherapy for treatment of wet AMD

Oraya® Therapeutics, Inc. announced today that initial three-year safety follow-up data from its INTREPID study of Oraya Therapy™ stereotactic radiotherapy for the treatment of wet age-related macular degeneration (AMD) were presented for the first time today during the America Academy of Ophthalmology’s (AAO) annual meeting in New Orleans.

KXL II from Avedro for Non-Surgical Correction of Myopia

Avedro (Boston, MA) received CE Mark clearance in Europe for its KXL II System that’s used for Accelerated Cross-linking and PiXL (Photorefractive Intrastromal Cross-linking) procedures for treatment of myopia.

“As one of the first KXL II clinical sites, we experienced the amazing capabilities of customized accelerated c (Read more...)